The UK private healthcare market is expanding as NHS pressures drive demand, with oncology emerging as a key growth area supported by partnerships like Bupa/HCA and HCA/The Christie. Private Medical Insurance (PMI) dominates funding, with Bupa, AXA PPP, Aviva, and Vitality holding 90% of the market. Although unique in structure, private providers share key prescribers with the NHS, creating opportunities to improve access to innovative treatments. Life sciences could capture up to 10% of private sector revenues, while private care also accelerates opportunities in NHS commissioning. IQVIA supports strategies through insights, stakeholder engagement, and training.

Join for free to read